自4月3日美国总统特朗普正式宣布"对等关税"以来，中美之间多次互相提高关税，目前双方相互加征的关税都已在100%以上。且随着贸易摩擦的升温，中美两国 之间的角力有着进一步向其他领域扩散的风险。 值得关注的是：① 近日美国财政部长曾表示， 不排除以在美上市的中概公司强制退市，作为两国间谈判的筹码之一；② 2月21日， 白宫发布了"America First Investment Policy"备忘录中，也提及了在一定情况下限制美国资金投资于部分中国公司/资产的可能性。 虽然上述两条潜在的风险截至目前仅停留在口头阶段，美国政府尚没有进行任何实质性的动作。但历史上，中概退市威胁并非没有先例： 2020年~2022年间美国政 府就曾以HFCAA法案下，无法获得中概上市公司的审计监管权的原因，正式推进过中概在美退市。 尽管后续中美两国政府达成了协议，中概从美股全面退市并没真正发生，但仍有中移动等公司在争端期间被美政府强制退市，后有如中国石油等在争端缓解后仍 主动选择退市。 由此可见，无论是 强制中概从美股退市、抑或禁止美国资金投资中国资产，虽然最终落地的概率应当非常小，但属于存在先例、不能视而不见的"黑天鹅"风险。 海 ...

Group 1 - *ST Jiyao has triggered the delisting condition due to its stock price closing below 1 yuan for 20 consecutive trading days, with the latest price at 0.21 yuan per share, reflecting an 83.59% decline year-to-date [2][5][6] - The stock will be suspended from trading starting April 24, 2025, and will not enter a delisting transition period [5][7] - The company has been experiencing continuous losses, with a projected net loss of 500 million to 850 million yuan for the fiscal year 2024, and an estimated net asset deficit of 1.18 billion to 830 million yuan [8] Group 2 - There has been a noticeable increase in cases of delisting due to stock prices falling below 1 yuan in the A-share market, with companies like *ST Xulan, *ST Jiayu, *ST Dongfang, and *ST Furun also receiving notices for potential delisting [3][10] - Other companies are also approaching the 1 yuan threshold, with *ST Pengbo's stock price at 0.76 yuan, *ST Jiu You at 1.18 yuan, and *ST Longjin fluctuating between 1.1 and 1.3 yuan [11][12]

绿康生化（002868）公告，预计2024年期末净资产为-2300万元，归属上市公司股东的净利润为亏损 4.35亿元–3.85亿元。根据《深圳证券交易所股票上市规则》规定，公司股票交易将在2024年年度报告披 露后被实施退市风险警示(*ST)。此外，公司股票也可能被实施其他风险警示(ST)，因公司最近连续三 个会计年度扣除非经常性损益前后净利润均为负值，且最近一年审计报告显示公司持续经营能力存在不 确定性。 ...

"资本市场不允许任何一家公司欺诈上市，就像一锅汤一样，一颗老鼠屎和十颗老鼠屎难道不一样吗？ 难道有一颗老鼠屎的汤就能喝？"吴晓求以此形象比喻当前市场中存在的欺诈问题。有些人总认为"大部 分上市公司是好的"，但资本市场不是靠大部分公司好就可以稳定运作的生态，只要有作假存在，整个 市场的透明度就会受到破坏，投资价值就失去了基础。 资本市场的本质是透明、公平和法治，如果没有严密的制度设计和有效的法律威慑，欺诈上 市、财务造假等乱象就难以遏制，投资者的信心也无从谈起。 全 文2694字 ，阅读约 需7分钟 新京报记者 肖隆平 编辑 郑伟 彬 校对 刘越 4月22日，在新京报主办的主题为"直面关税战，锻造经济韧性——2025新京智库春季论坛"上，中国人 民大学国家金融研究院院长、中国资本市场研究院院长吴晓求教授表示，资本市场的本质是透明、公平 和法治，如果没有严密的制度设计和有效的法律威慑，欺诈上市、财务造假等乱象就难以遏制，投资者 的信心也无从谈起。 有一颗老鼠屎的汤就不能喝 吴晓求强调，资本市场的风险收益率不是来自价格波动本身，而是来自企业的成长性、科技创新能力和 产业周期带来的不确定性。因此，上市公司的竞争力是资 ...

【4月23日，紫天科技仍处停牌状态】4月22日晚，紫天科技称原定于4月23日披露2024年年度报告及 2025年第一季度报告，因未聘请年审会计师，预计无法在4月30日法定期限披露。2024年5月20日，其聘 请北京亚泰国际会计师事务所为2024年度审计机构，2025年4月14日收到通知，因未签2024年度审计业 务约定书且欠付2023年度审计费用，亚泰国际不再合作。紫天科技表示将继续联络审计机构推进年报编 制及披露工作。因未完成整改被责令停牌，还面临退市风险。4月21日晚公告，因财务会计报告虚假记 载，收到福建证监局责令改正措施决定，要求3月16日前完成整改并提交报告，截至4月21日，尚未聘请 相关会计师事务所，也未提交整改报告，股票已于3月17日停牌。根据规定，若停牌后两个月内未完成 整改，股票交易可能被实施退市风险警示；再两个月内未完成整改，股票可能会被终止上市。紫天科技 主营业务含互联网广告、云服务、电商贸易等三大板块。2023年受大额资产减值影响，巨额亏损超12亿 元。1月27日晚发布2024年度业绩预告，预计净亏损1.5亿元至2.2亿元，上年同期净亏损12.1亿元。报告 期内，受行业因素影响，原有互 ...

Group 1 - The report highlights that there are currently no signals indicating a "forced delisting" risk for Chinese concept stocks from U.S. exchanges, despite heightened concerns due to recent political tensions and trade disputes [4][3]. - The "Foreign Companies Accountability Act" (HFCA) enacted in 2020 is a significant legislative measure that could lead to the delisting of Chinese companies if they fail to meet specific auditing and disclosure requirements for three consecutive years [4][9]. - The report emphasizes that the core advantage of returning to Hong Kong for Chinese companies lies in its flexibility and inclusiveness, which significantly reduces delisting risks compared to the U.S. market [6][12]. Group 2 - The report notes a continuous increase in the number of companies applying for listings in Hong Kong, with 67 applications submitted in the first quarter of 2025, reflecting a 281% year-on-year increase in IPO amounts [17][19]. - It mentions that 8.7% of Chinese concept companies are listed on both Hong Kong and U.S. exchanges, particularly among the top 50 companies [17][19]. - The report identifies key trends in industries seeking to list in Hong Kong, including pharmaceuticals, software services, and real estate, with a notable increase in IPO activities in the non-ferrous metals sector [19][23].

Core Viewpoint - Nanhua Biological (000504.SZ) significantly revised its 2024 annual performance forecast from a profit of 12.5 million to 15.5 million yuan to a loss of 19 million to 21 million yuan, triggering delisting risk warning conditions [1] Group 1: Performance Revision - The company’s 2024 net profit and net profit after deducting non-recurring gains and losses are both negative, with operating revenue below 300 million yuan, leading to a "*ST" designation for its stock [1] - The revision was attributed to return risks primarily related to the sales of the company's beauty products, as prior profit announcements were made before a comprehensive audit [5] Group 2: Business Transformation - Nanhua Biological has been transitioning towards beauty and anti-aging sectors, which are key areas of its recent business strategy, while previously being involved in real estate, media, biomedicine, and energy-saving industries [5] - The company has faced delisting risk warnings multiple times in the past due to consecutive years of losses, specifically in 2010, 2013, 2016, and 2019 [5] Group 3: Management and Control - The frequent changes in the company's business focus are linked to changes in its controlling shareholders, although the company asserts that there are no internal management issues or control deficiencies [5]

Group 1 - The company reported a significant decline in revenue for 2024, with total revenue of 237 million yuan, a year-on-year decrease of 33.55%, marking the third consecutive year of revenue decline [4][6] - The net profit attributable to shareholders was -89.94 million yuan, an improvement of 43.53% compared to the previous year's loss of 159 million yuan, indicating some progress in cost control and internal management [5][6] - Despite improvements in gross margin from 6.21% in 2023 to 11.44% in 2024, the absolute gross profit was only 27.1 million yuan, insufficient to cover operating costs due to the sharp decline in revenue [4][5] Group 2 - The company has faced continuous losses since 2021, with a cumulative loss exceeding 500 million yuan, highlighting ongoing concerns regarding profitability [5] - The net cash flow from operating activities was -70.45 million yuan, although this represented a 9.6% year-on-year improvement, it still indicates significant cash flow pressure [5] - In response to the risk of delisting, the company plans to implement measures such as revitalizing fixed assets, accelerating inventory turnover, and exploring new market opportunities, while also acquiring a 51% stake in a clean energy company to seek new growth points [6]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000584 证券简称：*ST工智（维权） 公告编号：2025-057 江苏哈工智能机器人股份有限公司 一、银行账户解除冻结基本情况 上海我耀机器人有限公司（以下简称"上海我耀"）与库卡柔性系统（上海）有限公司（以下简称"库卡 柔性"）采购合同纠纷一案，上海国际仲裁中心裁决不予支持库卡柔性的全部仲裁请求，相关部门从而 解除了因该案冻结上海我耀的部分银行账户；海宁市译联机器人制造有限公司（以下简称"译联机器 人"）与公司、海宁我耀合同纠纷一案，译联机器人向法院申请财产保全。后各方已达成经法院裁定有 效的调解协议，现本案已执行完毕，法院已解除海宁我耀之前持有的浙江哈工机器人有限公司的100% 股权（海宁我耀持有的浙江哈工100%股权于2024年10月变更登记至吴淳名下），且对公司部分银行账 户资金的冻结。以下是解除冻结的银行账户明细： ■ 二、本次公司银行账户新增冻结情况 因刘延中先生与公司、吉林市江机民科实业有限公司（以下简称"江机民科"）股权转让纠纷一案，公司 银行账户因诉讼相对方向法院申请强制执行而被冻结。以下是冻结的银行账户明细。 关于公司、子公 ...

Core Viewpoint - Qinghai Huading Industrial Co., Ltd. reported a net profit attributable to shareholders of the parent company of -89,935,284.53 yuan for the year 2024, leading to a proposal of no profit distribution or capital reserve transfer to share capital for the year [4][21]. Company Overview - Qinghai Huading primarily engages in the manufacturing of elevator components and gearboxes, with a focus on research, production, and sales. The company has faced challenges due to a weak real estate market and increased competition in the engineering machinery sector [5][11]. - The company completed the acquisition of 51% of Mangya Yuanxin Energy Co., Ltd., expanding its operations into natural gas, including LNG and CNG [5][12]. Financial Data and Indicators - The company reported a significant decline in net profit for 2024, with a total net loss of approximately 89.94 million yuan and accumulated undistributed profits of about -1.05 billion yuan [4][21]. - The company is subject to a delisting risk warning due to its financial performance, as it failed to meet the revenue threshold of 300 million yuan [14][60]. Major Events and Changes - The company’s subsidiaries have experienced revenue declines due to the downturn in the elevator industry, prompting efforts to develop new clients and business lines [11][12]. - The company has implemented measures to optimize production processes and reduce costs in response to market fluctuations [11][12]. Shareholder Information - The controlling shareholder, Qinghai Heavy Machine Tool Co., Ltd., holds a significant portion of voting rights, influencing the company's governance [7][8]. - Recent changes in control have occurred, with Wang Feng becoming the actual controller of the company, increasing his voting rights to 15.26% [9]. Risk Warning and Future Plans - The company is under a delisting risk warning due to its financial performance, with plans to enhance liquidity and reduce operational risks through asset management and market expansion [14][63]. - Strategies for 2025 include improving inventory turnover, exploring new markets, and enhancing internal controls to mitigate operational risks [63][64].